EuroBiotech: More Articles of Note

Newspapers

> Millendo Therapeutics bought France’s Alizé Pharma. Statement 

> Summit Therapeutics offloaded the Latin American rights to its Clostridium difficile infection drug. Statement

> The EMA’s drug review committee recommended the approval of TiGenix and Takeda’s allogeneic stem cell therapy. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.

> Active Biotech warned it must sell a property or otherwise raise money before the end of February, otherwise it “will not have funding for the coming twelve-month period.” Statement

> The FDA awarded qualified infectious disease product status to Basilea Pharmaceutica’s ceftobiprole. Release 

> Ablynx posted data from a Japanese ethno-bridging study of caplacizumab. Statement 

> BiomX bought RondinX to expand its microbiome discovery and development capabilities. Release